Article
VEGF 936C>T polymorphism and breast cancer risk: evidence from 5,729 cases and 5,868 controls.
Breast cancer research and treatment - 1 Jan 2011
Gu Dongying, Wang Meilin
Abstract excerpt
Vascular endothelial growth factor (VEGF) is one of the most potent endothelial cell mitogens and plays an important role in angiogenesis. Many published studies have evaluated the association between the VEGF 936C>T polymorphism and breast cancer risk. However, the published findings are inconsistent. In order to derive a more precise estimation of the association, a meta-analysis was performed in this study. A...
Topics
- Breast Neoplasms
- Case-Control Studies
- Female
- Gene Frequency
- Genetic Predisposition to Disease
- Humans
- Polymorphism, Single Nucleotide
- Risk
- Risk Assessment
- Risk Factors
- Vascular Endothelial Growth Factor A